Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Dermatomyositis
Reports summarize dermatomyositis in children study results from Northwestern University
April 11th, 2007
Investigators publish new data in the report "RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis." In this recent study, researchers in the United States conducted a study "To determine bone mineral density (BMD) in patients at the time of diagnosis of juvenile dermatomyositis (DM), to compare the RANKL:osteoprotegerin (OPG) ratio in patients with juvenile DM with that in healthy control subjects, and to evaluate whether BMD is associated with the RANKL:OPG ratio and the duration of untreated disease. Thirty-seven children with juvenile DM were enrolled." "Dual x-ray absorptiometry (DXA) was performed before...
Source: Immunotherapy Weekly (2007-04-11)
|
